Cancer remains one of the leading causes of morbidity and mortality globally, with India reporting over 1.4 million new cases annually.
South India has emerged as a major hub for oncology care.
States like Karnataka, Tamil Nadu, Kerala, and Andhra Pradesh host specialized cancer centres that provide comprehensive care, from early detection to advanced therapies such as immunotherapy and precision oncology.
India has increasingly become a preferred destination for cancer care and other advanced treatments under the growing sector of medical tourism. According to the Medical Tourism Index (MTI) 2020–2021, India ranks 10th globally out of 46 destinations, reflecting its strong position in affordable and high-quality healthcare delivery.
The country attracts patients from regions such as South Asia, the Middle East, Africa sometimes even Britain due to significantly lower treatment costs, often 65–90% cheaper than in developed nations, combined with access to advanced technologies and skilled specialists immediately. Government initiatives, including the expansion of e-medical visas and a national strategy for medical value travel, have further supported this growth. Additionally, foreign patient inflow has shown a steady rise, with medical tourist arrivals increasing from 1.83 lakh in 2020 to over 3 lakh in 2021, indicating recovery and expansion post-pandemic.
This combination of affordability, infrastructure, and policy support continues to position India as a major hub for international patients seeking specialized care, including oncology treatments.
A flagship centre of the HCG oncology network, established in 1989 as Bangalore Institute of Oncology (BIO) this hospital is known for its high-end treatment technologies, including CyberKnife, robotic surgery, and adaptive radiation therapy. The hospital follows a multidisciplinary care model, integrating surgical, medical, and radiation oncology under one roof.
Started in 2023 with dedicated 150-bed oncology facility, MGM Cancer Institute offers comprehensive, evidence-based cancer care, including immunotherapy, targeted therapy, and advanced diagnostics. The centre emphasizes AI-enabled imaging and precision oncology for accurate staging and treatment planning.
One of India’s first proton therapy centres, this hospital specializes in high-precision radiation therapy that minimizes damage to surrounding tissues. It is particularly significant for treating complex and pediatric cancers, where precision is critical with its most advanced technology. It is comparatively a new centre, established only in 2019.
Established in 1981, a government-supported tertiary cancer centre, RCC plays a major role in cancer research, prevention, and treatment in Kerala. It is known for population-based cancer registries, affordable treatment, and public health outreach programs.
See also: Legacy of Dr. C.P. Mathew: Kerala’s Pioneer in Integrative Cancer Care
A long-standing institution in Thrissur, Kerala, established in 1978, Amala Cancer hospital and Research Centre is recognized for its oncology research, radiotherapy services and surgical oncology expertise. It contributes significantly to academic oncology and clinical training.
Member of the International Tumor Board, this institute is situated in Citizens Specialty hospital in Hyderabad and offers evidence-based cancer care protocols, multidisciplinary tumour boards, and access to global oncology practices and technologies. The hospital receives services from specialists all over the world. It was established in 2012 and a leading cancer centre in South Asia.
The Christian Medical College Vellore Cancer Centre, Tamil Nadu is a leading institution known for advanced, multidisciplinary cancer care, including surgery, chemotherapy, and radiation therapy. Established in 1939, the Department of Radiation Oncology has over 85 years of excellence in treatment and research. Upholding CMC’s vision, it provides compassionate, holistic, and state-of-the-art care to patients across India and beyond.
Hospitals increasingly use robotic surgery, proton therapy, AI-based diagnostics, and precision medicine, improving treatment accuracy and outcomes.
Most leading centres follow tumour board-based decision-making, integrating specialists from different oncology fields.
Institutions are actively participating in clinical research and trials, both international and national, contributing to innovation in cancer therapies.
Government and non-profit centres are improving affordability and outreach, especially in Kerala and Andhra Pradesh.
South India has established itself as a major centre for oncology care in India, combining advanced medical technology, research-driven treatment approaches, and a strong network of specialized cancer hospitals.
From high-precision proton therapy in Chennai to research-driven public cancer centres in Kerala and advanced robotic oncology in Bengaluru, the region continues to play a crucial role in improving access to comprehensive cancer care.
(TL)